Is there a role for lung perfusion [99mTc]-MAA SPECT/CT to rule out pulmonary embolism in COVID-19 patients with contraindications for iodine contrast?
Open Access
- 30 April 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 47 (9), 2062-2063
- https://doi.org/10.1007/s00259-020-04837-4
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Diagnostic Evaluation of Pulmonary Embolism During the COVID-19 PandemicJournal of Nuclear Medicine, 2020
- COVID-19 Complicated by Acute Pulmonary EmbolismRadiology: Cardiothoracic Imaging, 2020
- Acute pulmonary embolism and COVID-19 pneumonia: a random association?European Heart Journal, 2020
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 2020
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Cardiovascular complications of acute respiratory infections: current research and future directionsExpert Review of Anti-infective Therapy, 2019